Other

Granted (in shares)

Analysis

StatementIncome Statement
SectionOther
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2025
Last reportedQ4 2025Feb 13, 2026

How to read this metric

Increasing share grants relative to total shares outstanding can signal potential dilution and changes in compensation structure.

Detailed definition

The aggregate number of shares underlying equity-based compensation awards granted during the period. This provides insi...

Peer comparison

Comparable across all firms utilizing stock-based compensation as part of their total rewards strategy.

Metric ID: other_share_based_compensation_arrangements_by_share_bas_099e66

Historical Data

1 periods
 Q4 '25
Value$502.97

Granted (in shares) at Other Companies

General Motors logo
General MotorsGMView metric
Arthur J. Gallagher logo
Arthur J. GallagherAJGView metric
General Motors logo
General MotorsGMView metric
EFC
Ellington Financial Inc.EFCView metric
3M logo
3MMMMView metric
RBC Bearings logo
RBC BearingsRBCView metric

Frequently Asked Questions

What is Vertex Pharmaceuticals's granted (in shares)?
Vertex Pharmaceuticals (VRTX) reported granted (in shares) of $502.97 in Q4 2025.
What does granted (in shares) mean?
Number of shares granted under equity compensation plans.